TPX2 (DIL-2): A Potent Drug Target and Potential Biomarker for Various Diseases

Target Name: TPX2

NCBI ID: G22974

TPX2

TPX2 (DIL-2): A Potent Drug Target and Potential Biomarker for Various Diseases

Introduction

TPX2 (double-stranded RNA-protein hybrid), also known as DIL-2, is a non-coding RNA molecule that plays a crucial role in various cellular processes, including cell growth, differentiation, and inflammation. TPX2 has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

Structure and Function

TPX2 is a 22-kDa RNA molecule that consists of two distinct regions: the first region is a double-stranded RNA, and the second region is a protein that is derived from the gene ZNF2. The double-stranded RNA region encodes a unique RNA structure that is highly conserved in various species, including humans. The protein region of TPX2 is a 191-kDa protein that contains four conserved cysteine 鈥嬧?媟esidues, which are involved in protein-protein interactions and other cellular processes.

TPX2 is a potent drug target because it can interact with multiple protein molecules, including the oncogene transforming growth factor-尾1 (TGF-β1) and the tumor suppressor protein, p53. TGF-β1 is a key mediator of cellular processes that promote cell growth , including the regulation of cell adhesion, differentiation, and survival. TPX2 has been shown to interact with TGF-β1 and has been proposed as a potential inhibitor of TGF-β1-mediated signaling pathways.

In addition to its potential impact on TGF-β1, TPX2 has also been shown to interact with several other proteins, including the transcription factor, NF-kappa-B. NF-kappa-B is a protein that plays a role in the regulation of inflammation, immune responses , and cell survival. TPX2 has been shown to interact with NF-kappa-B and has been proposed as a potential NF-kappa-B inhibitor.

TPX2 has also been shown to have a role in the regulation of cell apoptosis, which is the process by which cells die when they have reached their lifespan. Apoptosis is a natural process that helps the body eliminate damaged or dysfunctional cells. TPX2 has also been shown to play a role in the regulation of cell apoptosis by activating the B-cell apoptosis pathway.

In addition to its potential impact on cell apoptosis, TPX2 has also been shown to have a role in the regulation of cell signaling pathways, including the TGF-β1 signaling pathway. TPX2 has also been shown to regulate the translation of mRNAs in the TGF-β1 signaling pathway by binding to the RNA-protein interface of the TGF-β1 complex.

Drug Target Interactions

TPX2 has been shown to interact with multiple drug targets, including the oncogene transforming growth factor-尾1 (TGF-β1), the tumor suppressor protein, p53, the transcription factor, NF-kappa-B, and the B-cell apoptosis pathway. TPX2 has has been shown to inhibit the activity of TGF-β1 by binding to its RNA-protein interface, which results in the inhibition of TGF-β1-mediated signaling pathways.

TPX2 has also been shown to inhibit the activity of NF-kappa-B by binding to its nuclear localization domain. NF-kappa-B is a protein that plays a role in the regulation of inflammation, immune responses, and cell survival, and its activity is regulated by several factors, including the protein

Protein Name: TPX2 Microtubule Nucleation Factor

Functions: Spindle assembly factor required for normal assembly of mitotic spindles. Required for normal assembly of microtubules during apoptosis. Required for chromatin and/or kinetochore dependent microtubule nucleation. Mediates AURKA localization to spindle microtubules (PubMed:18663142, PubMed:19208764). Activates AURKA by promoting its autophosphorylation at 'Thr-288' and protects this residue against dephosphorylation (PubMed:18663142, PubMed:19208764). TPX2 is inactivated upon binding to importin-alpha (PubMed:26165940). At the onset of mitosis, GOLGA2 interacts with importin-alpha, liberating TPX2 from importin-alpha, allowing TPX2 to activates AURKA kinase and stimulates local microtubule nucleation (PubMed:26165940)

The "TPX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TPX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets